全球合成生物學工具市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計合成生物學工具市場將從 2025 年的 193 億美元成長到 2034 年的 843.6 億美元，2026 年至 2034 年的複合年成長率為 17.81%。

隨著生物學與工程學的融合推動醫療保健、農業和工業生物技術領域的創新，全球合成生物學工具市場正在迅速擴張。 CRISPR基因編輯系統、DNA合成平台和先進的生物資訊軟體等合成生物學工具，能夠以前所未有的方式控制生物系統。這些進步正在加速藥物研發、作物改良、生質燃料開發和永續化學品生產等領域的應用。

高通量自動化、糾錯技術以及成本效益高的基因合成技術的不斷改進，正在使合成生物學技術更加普及。雲端平台和人工智慧驅動的分析技術的整合，正在簡化資料管理並加速設計-建構-測試-學習（DBTL）週期。學術機構和Start-Ups正在加強與行業領導者的合作，以開發具有商業性潛力的新型合成途徑和設計生物體。

未來的機會在於可程式設計細胞療法、用於環境監測的生物感測器以及能夠按需進行生物設計的生物鑄造廠。隨著全球各產業優先考慮永續性和循環生物經濟模式，合成生物學工具將在以可再生生物替代方案取代石油基製程方面發揮核心作用。這個市場將繼續作為下一代生物技術的基石，並有望在多個領域釋放變革性創新。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球合成生物學工具市場：依產品分類

• 市場分析、洞察與預測
• 寡核苷酸/寡核苷酸叢集和合成DNA
• 酵素
• 克隆技術套件
• 異源核酸
• 基本生物

第5章 全球合成生物學工具市場：依技術分類

• 市場分析、洞察與預測
• 次世代定序技術
• PCR技術
• 基因組編輯技術
• 生物加工技術
• 其他技術

第6章 全球合成生物學工具市場：依應用領域分類

• 市場分析、洞察與預測
• 衛生保健
• 除了醫療保健之外

第7章 全球合成生物學工具市場：依最終用途分類

• 市場分析、洞察與預測
• 生物技術和製藥公司
• 學術研究機構
• 其他

第8章 全球合成生物學工具市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bota Biosciences Inc
  • Codexis Inc
  • Creative Biogene
  • Creative Enzymes
  • Enbiotix Inc
  • Illumina Inc
  • Merck KGaA（Sigma-Aldrich Co. LLC）
  • New England Biolabs
  • Eurofins Scientific
  • Novozymes
  • Pareto Bio Inc

The Synthetic Biology Tools Market size is expected to reach USD 84.36 Billion in 2034 from USD 19.30 Billion (2025) growing at a CAGR of 17.81% during 2026-2034.

The global synthetic biology tools market is expanding rapidly as the convergence of biology and engineering drives innovation across healthcare, agriculture, and industrial biotechnology. Synthetic biology tools such as CRISPR gene-editing systems, DNA synthesis platforms, and advanced bioinformatics software are enabling unprecedented control over biological systems. These advancements are accelerating applications in drug discovery, crop engineering, biofuel development, and sustainable chemical production.

Continuous improvements in high-throughput automation, error-correction methods, and cost-efficient gene synthesis are democratizing access to synthetic biology capabilities. Integration with cloud-based platforms and AI-driven analytics is streamlining data management, facilitating faster design-build-test-learn (DBTL) cycles. Academic institutions and startups are increasingly collaborating with industry leaders to develop novel synthetic pathways and engineered organisms with commercial potential.

Future opportunities lie in programmable cell therapies, biosensors for environmental monitoring, and biofoundries capable of on-demand organism design. As global industries prioritize sustainability and circular bioeconomy models, synthetic biology tools will play a central role in replacing petroleum-based processes with renewable biological alternatives. The market is set to remain a cornerstone of next-generation biotechnology, unlocking transformative innovations across multiple sectors.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotide/Oligo Pools and Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism

By Technology

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies

By Application

• Healthcare
• Non-healthcare

By End Use

• Biotechnology and Pharmaceutical companies
• Academic and Research Institutes
• Others

COMPANIES PROFILED

• Bota Biosciences Inc, Codexis Inc, Creative Biogene, Creative Enzymes, Enbiotix Inc, Illumina Inc, Merck KGaA SigmaAldrich Co LLC, New England Biolabs, Eurofins Scientific, Novozymes, Pareto Bio Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotide/Oligo Pools and Synthetic DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cloning Technologies Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Xeno-Nucleic Acids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Chassis Organism Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. NGS Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Genome Editing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Bioprocessing Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Non-healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Biotechnology and Pharmaceutical companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SYNTHETIC BIOLOGY TOOLS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Application
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Application
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Application
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Application
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Application
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SYNTHETIC BIOLOGY TOOLS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bota Biosciences Inc
  • 10.2.2 Codexis Inc
  • 10.2.3 Creative Biogene
  • 10.2.4 Creative Enzymes
  • 10.2.5 Enbiotix Inc
  • 10.2.6 Illumina Inc
  • 10.2.7 Merck KGaA (Sigma-Aldrich Co. LLC)
  • 10.2.8 New England Biolabs
  • 10.2.9 Eurofins Scientific
  • 10.2.10 Novozymes
  • 10.2.11 Pareto Bio Inc